Amoebic gill disease (AGD) is considered to be the most significant health problem for farmed Atlantic salmon in Tasmania, costing the industry an estimated $15-20 million pa. It is caused by the presence of Neoparamoeba spp. on the gills and if untreated can lead to death. Although some control of...
This project has increased our knowledge of Amoebic Gill Disease, in particular about the pathogen and the dynamics of infection. We have described a new species of neoparamoeba, Neoparamoeba perurans, and showed that it has been consistently associated with AGD worldwide. Stocking...
Before this project our knowledge of the effects of husbandry on Amoebic Gill Disease (AGD) was limited. This project allowed on-farm assessment of effects of husbandry procedures and stock characteristics on AGD severity. Furthermore, we investigated the potential to re-use fresh water for...
Prior to this project there had been investigations into some potential candidate amoebicides, with little success except for the possibility of oxidative disinfectants such as chloramine-T. This project has since tested a number of amoebicides using a progressive approach of in vitro...
Before this project our knowledge of immune response in Amoebic Gill Disease (AGD) was fundamentally limited and more information was required to assess the potential for immunomodulators in the management of AGD.
We confirmed that injection of bacterial DNA motif (CpG oligonucleotides) six...
This project updated the Australian Seafood Quality Index manual with eight new species
For copies of the manual please contact markb@sydneyfishmarket.com.au
For the Quality Index on a free app platform, visit the iTunes or Android stores and search for 'Australian Seafood Quality...
This project implemented the agreed Strategic R&D Plan for the salmon industry for the period 2003-2006. It provided an economical administrative framework and processes which:
Engaged stakeholders, specifically the salmon farming industry and the State managers responsible for its...